New insights into the pathophysiology of diabetic nephropathy: from haemodynamics to molecular pathology

No abstract is available for this paper.

• Publication year

  2004

• Venue

  European Journal of Clinical Investigation

• Publication date

  2004-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1365-2362.2004.01429.xPMID 15606719
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Advanced glycation end products induce tubular epithelial-myofibroblast transition through the RAGE-ERK1/2 MAP kinase signaling pathway.

  2004cited by this paper
• Activation of a local tissue angiotensin system in podocytes by mechanical strain.

  2004cited by this paper
• Upstream stimulatory factor (USF) proteins induce human TGF-beta1 gene activation via the glucose-response element-1013/-1002 in mesangial cells: up-regulation of USF activity by the hexosamine biosynthetic pathway.

  2004cited by this paper
• A genome scan for diabetic nephropathy in African Americans.

  2004cited by this paper
• Mediators of Diabetic Renal Disease: The Case for TGF-β as the Major Mediator

  2004cited by this paper
• The role of vascular endothelial growth factor (VEGF) in renal pathophysiology.

  2004cited by this paper
• Effect of high glucose on gene expression in mesangial cells: upregulation of the thiol pathway is an adaptational response.

  2004cited by this paper
• Angiotensin II, via AT1 and AT2 receptors and NF-kappaB pathway, regulates the inflammatory response in unilateral ureteral obstruction.

  2004cited by this paper
• Low-Dose Therapy With the Long-Acting Erythropoietin Analogue Darbepoetin Alpha Persistently Activates Endothelial Akt and Attenuates Progressive Organ Failure

  2004cited by this paper
• Kidney function in early diabetes: the tubular hypothesis of glomerular filtration.

  2004cited by this paper
• Erythropoietin: is it more than correcting anaemia?

  2004cited by this paper
• Anemia and end-stage renal disease in patients with type 2 diabetes and nephropathy.

  2004cited by this paper
• Aldosterone Potentiates Angiotensin II–Induced Signaling in Vascular Smooth Muscle Cells

  2004cited by this paper
• Interactions between angiotensin II and NF-kappaB-dependent pathways in modulating macrophage infiltration in experimental diabetic nephropathy.

  2004cited by this paper
• Association between mannose-binding lectin and vascular complications in type 1 diabetes.

  2004cited by this paper
• Protein Glycation: A Firm Link to Endothelial Cell Dysfunction

  2004cited by this paper
• NF-kappaB activation and overexpression of regulated genes in human diabetic nephropathy.

  2004cited by this paper
• Development of albuminuria and glomerular lesions in normoglycemic B6 recipients of db/db mice bone marrow: the role of mesangial cell progenitors.

  2004cited by this paper
• Mediators of diabetic renal disease: the case for tgf-Beta as the major mediator.

  2004cited by this paper
• Angiotensin II type 1 receptor overexpression in podocytes induces glomerulosclerosis in transgenic rats.

  2004cited by this paper
• High glucose concentration stimulates intracellular renin activity and angiotensin II generation in rat mesangial cells.

  2004cited by this paper
• Aldosterone in the development and progression of renal injury.

  2004cited by this paper
• Targeted deletion of angiotensin II type 1A receptor does not protect mice from progressive nephropathy of overload proteinuria.

  2004cited by this paper
• A 63bp deletion in the promoter of rage correlates with a decreased risk for nephropathy in patients with type 2 diabetes.

  2004cited by this paper
• Antihypertensive Treatment and Renal Damage: Amlodipine Exerts Protective Effect through the Polyol Pathway

  2004cited by this paper
• Fractalkine and Its Receptor, CX3CR1, Upregulation in Streptozotocin-Induced Diabetic Kidneys

  2004cited by this paper
• Angiotensin II Induces Hypoxia-Inducible Factor-1α in PC 12 Cells through a Posttranscriptional Mechanism: Role of AT2 Receptors

  2004cited by this paper
• Regulation of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF-A) expression in podocytes.

  2004cited by this paper
• Rapid change of glucose concentration promotes mesangial cell proliferation via VEGF: inhibitory effects of thiazolidinedione.

  2004cited by this paper
• Diminished loss of proteoglycans and lack of albuminuria in protein kinase C-alpha-deficient diabetic mice.

  2004cited by this paper
• Treating anemia early in renal failure patients slows the decline of renal function: a randomized controlled trial.

  2004cited by this paper
• Spironolactone prevents early renal injury in streptozotocin-induced diabetic rats.

  2004cited by this paper
• Diabetic Nephropathy: An Inherited Disease or Just a Diabetic Complication?

  2003cited by this paper
• CTGF Mediates TGF-– Induced Fibronectin Matrix Deposition by Upregulating Active 5 1 Integrin in Human Mesangial Cells

  2003cited by this paper
• Genomic strategies for diabetic nephropathy.

  2003cited by this paper
• Blockade of maitotoxin-induced endothelial cell lysis by glycine and L-alanine.

  2003cited by this paper
• Glycation, Inflammation, and RAGE: A Scaffold for the Macrovascular Complications of Diabetes and Beyond

  2003cited by this paper
• Remission and regression of diabetic nephropathy.

  2003cited by this paper
• BMP7 antagonizes TGF-beta -dependent fibrogenesis in mesangial cells.

  2003cited by this paper
• Is podocyte injury relevant in diabetic nephropathy? Studies in patients with type 2 diabetes.

  2003cited by this paper
• Effectiveness of Aldosterone Blockade in Patients With Diabetic Nephropathy

  2003cited by this paper
• The Pattern Recognition Receptor (RAGE) Is a Counterreceptor for Leukocyte Integrins

  2003cited by this paper
• Regression of microalbuminuria in type 1 diabetes.

  2003cited by this paper
• Reversal of glomerulosclerosis after high-dose enalapril treatment in subtotally nephrectomized rats.

  2003cited by this paper
• Extracellular matrix metabolism in diabetic nephropathy.

  2003cited by this paper
• Revisions to Instructions to JASN Authors Regarding Articles Reporting Studies Using DNA Arrays, DNA Polymorphisms, and Randomized Controlled Clinical Trials

  2003cited by this paper
• Molecular motors

  2003cited by this paper
• Growth factors and the development of diabetic nephropathy

  2003cited by this paper
• CTGF mediates TGF-beta-induced fibronectin matrix deposition by upregulating active alpha5beta1 integrin in human mesangial cells.

  2003cited by this paper
• Involvement of transforming growth factor-beta in regulation of calcium transients in diabetic vascular smooth muscle cells.

  2003cited by this paper
• Microvascular basement membranes in diabetes mellitus

  2003cited by this paper
• ACE-inhibitors but not endothelin receptor blockers prevent podocyte loss in early diabetic nephropathy

  2003cited by this paper
• Renin-angiotensin system activation and interstitial inflammation in human diabetic nephropathy.

  2003cited by this paper
• BMP7 antagonizes TGF-β-dependent fibrogenesis in mesangial cells

  2003cited by this paper
• Uric Acid Stimulates Monocyte Chemoattractant Protein‐1 Production in Vascular Smooth Muscle Cells Via Mitogen‐Activated Protein Kinase and Cyclooxygenase‐2

  2003cited by this paper
• Hyperfiltration and glomerulosclerosis.

  2003cited by this paper
• Role of megalin in endocytosis of advanced glycation end products: implications for a novel protein binding to both megalin and advanced glycation end products.

  2003cited by this paper
• Role of 12-lipoxygenase in the stimulation of p38 mitogen-activated protein kinase and collagen alpha5(IV) in experimental diabetic nephropathy and in glucose-stimulated podocytes.

  2003cited by this paper
• Overview of glucose signaling in mesangial cells in diabetic nephropathy.

  2003cited by this paper
• Adiposity Elevates Plasma MCP-1 Levels Leading to the Increased CD11b-positive Monocytes in Mice*

  2003cited by this paper
• Mycophenolate mofetil prevents the development of glomerular injury in experimental diabetes.

  2003cited by this paper
• Mechanism of increased angiotensin II levels in glomerular mesangial cells cultured in high glucose.

  2003cited by this paper
• Diabetic nephropathy in type 2 diabetes prevention and patient management.

  2003cited by this paper
• Erk 1,2 phosphorylates p27Kip1: Functional evidence for a role in high glucose-induced hypertrophy of mesangial cells

  2003cited by this paper
• Chymase is upregulated in diabetic nephropathy: implications for an alternative pathway of angiotensin II-mediated diabetic renal and vascular disease.

  2003cited by this paper
• After all those fat years: renal consequences of obesity.

  2003cited by this paper
• Angiotensin II receptor antagonists and angiotensin-converting enzyme inhibitors lower in vitro the formation of advanced glycation end products: biochemical mechanisms.

  2002cited by this paper
• The inflammatory component in progressive renal disease--are interventions possible?

  2002cited by this paper
• Podocyte number in normotensive type 1 diabetic patients with albuminuria.

  2002cited by this paper
• Essential role(s) of the intrarenal renin-angiotensin system in transforming growth factor-beta1 gene expression and induction of hypertrophy of rat kidney proximal tubular cells in high glucose.

  2002cited by this paper
• High glucose stimulates angiotensinogen gene expression via reactive oxygen species generation in rat kidney proximal tubular cells.

  2002cited by this paper
• Differential expression of type IV collagen isoforms in rat glomerular endothelial and mesangial cells.

  2002cited by this paper
• Expression of the slit-diaphragm protein, nephrin, in experimental diabetic nephropathy: differing effects of anti-proteinuric therapies.

  2002cited by this paper
• Clinical practice. Nephropathy in patients with type 2 diabetes.

  2002cited by this paper
• Angiotensin II activates nuclear transcription factor-kappaB through AT1 and AT2 receptors.

  2002cited by this paper
• The Renin-Angiotensin System and Progression of Renal Disease: From Hemodynamics to Cell Biology

  2002cited by this paper
• Novel Aspects of Transforming Growth Factor-Beta in Diabetic Kidney Disease

  2002cited by this paper
• Nephropathy in Patients with Type 2 Diabetes

  2002cited by this paper
• Angiotensin II activates nuclear transcription factor-κB through AT1 and AT2 receptors11See Editorial by Luft, p. 2272.

  2002cited by this paper
• Advanced glycation end-products: a review

  2001cited by this paper
• High Glucose-Induced Hypertrophy of Mesangial Cells Requires p27Kip1, an Inhibitor of Cyclin-Dependent Kinases

  2001cited by this paper
• Diabetic nephropathy: prevention and treatment.

  2001cited by this paper
• Advanced glycation end products and the progressive course of renal disease.

  2001cited by this paper
• Podocyte foot process broadening in experimental diabetic nephropathy: amelioration with renin-angiotensin blockade

  2001cited by this paper
• Progression, remission, regression of chronic renal diseases.

  2001cited by this paper
• Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice.

  2001cited by this paper
• High Glucose-Induced Hypertrophy of Mesangial Cells Requires p 27 Kip 1 , an Inhibitor of Cyclin-Dependent Kinases

  2001cited by this paper
• The renin-angiotensin system in diabetic nephropathy.

  2001cited by this paper
• Glucose-modified proteins modulate essential functions and apoptosis of polymorphonuclear leukocytes.

  2001cited by this paper
• High glucose-induced hypertrophy of mesangial cells requires p27(Kip1), an inhibitor of cyclin-dependent kinases.

  2001cited by this paper
• Glomerular cell number in normal subjects and in type 1 diabetic patients.

  2001cited by this paper
• Literature abstracts

  2001cited by this paper
• Podocyte injury underlies the progression of focal segmental glomerulosclerosis in the fa/fa Zucker rat.

  2001cited by this paper
• Antisense GLUT-1 protects mesangial cells from glucose induction of GLUT-1 and fibronectin expression.

  2001cited by this paper
• Irbesartan normalises the deficiency in glomerular nephrin expression in a model of diabetes and hypertension

  2001cited by this paper
• Putative pathophysiological role of growth factors and cytokines in experimental diabetic kidney disease

  2000cited by this paper
• Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice.

  2000cited by this paper
• Structural involvement in type 1 and type 2 diabetic nephropathy.

  2000cited by this paper
• Role of Growth Factors in the Development of Diabetic Complications

  2000cited by this paper
• Early events leading to renal injury in obese Zucker (fatty) rats with type II diabetes.

  2000cited by this paper

• Integrated Bioinformatic Analysis of the Shared Molecular Mechanisms Between Diabetic Nephropathy and Atherosclerosis

  2026influential citation
• Metformin attenuates endoplasmic reticulum stress in diabetic kidney disease: mechanistic insights and future perspectives

  2025cites this paper
• Research Advances on Biomarkers for Early Diagnosis of Diabetic Nephropathy

  2025cites this paper
• The β2-adrenoceptor agonist formoterol reverses metabolic dysfunction in the diabetic proximal tubule.

  2025cites this paper
• TangNaikang Formula Alleviates Podocyte Injury in Diabetic Nephropathy by Modulating the SHIP2/PI3K/AKT Pathway

  2025cites this paper
• Antibiotic-Loaded Hydroxyapatite Ceramic in the Management of Diabetic Foot Osteomyelitis: An Investigation of Factors That Determine Patient Outcomes

  2025cites this paper
• Mechanism of Astragali radix Combined with Salviae miltiorrhizae Radix et Rhizoma in Alleviating Diabetic Nephropathy: Focus on the AGEs/RAGE/MAPK Signaling Pathway.

  2025cites this paper
• Molecular mechanisms of diabetic nephropathy: A narrative review

  2024cites this paper
• Inhibitory effects of nelumbo nucifera flower extract against diabetes mellitus TYPE II

  2024cites this paper
• Role of Quercetin in DNA Repair: Possible Target to Combat Drug Resistance in Diabetes.

  2024cites this paper
• Clinical applications and mechanism insights of natural flavonoids against type 2 diabetes mellitus

  2024cites this paper
• Partridge tea polyphenols alleviated STZ-induced diabetic nephropathy by regulating Keap1/Nrf2/ARE signaling pathway in C57BL/6 mice

  2024cites this paper
• Deciphering characteristics of Macaranga tanarius leaves extract with electron shuttle-associated anti-inflammatory activity via microbial fuel cells, molecular docking, and network pharmacology

  2024cites this paper
• Role of Bile Acid Receptors in the Development and Function of Diabetic Nephropathy

  2024cites this paper
• Wogonin upregulates SOCS3 to alleviate the injury in Diabetic Nephropathy by inhibiting TLR4-mediated JAK/STAT/AIM2 signaling pathway

  2024cites this paper
• Association of the dietary inflammatory index with complicated diabetic kidney disease in people with diabetes mellitus: evidence from NHANES 2009–2018

  2024cites this paper
• Targeting the epidermal growth factor receptor (EGFR/ErbB) for the potential treatment of renal pathologies

  2024cites this paper
• Identification of key genes in diabetic nephropathy based on lipid metabolism

  2024cites this paper
• Ferroptosis: an important player in the inflammatory response in diabetic nephropathy

  2023cites this paper
• ASH2L-mediated H3K4me3 drives diabetic nephropathy through HIPK2 and Notch1 pathway.

  2023cites this paper
• Could Systemic Inflammatory Index Predict Diabetic Kidney Injury in Type 2 Diabetes Mellitus?

  2023cites this paper
• Role of ADMA in the pathogenesis of microvascular complications in type 2 diabetes mellitus

  2023cites this paper
• Diabetische Nephropathie

  2023cites this paper
• Breviscapine alleviates podocyte injury by inhibiting NF-κB/NLRP3-mediated pyroptosis in diabetic nephropathy

  2023cites this paper
• Long non-coding RNA MEG3 silencing weakens high glucose-induced mesangial cell injury by decreasing LIN28B expression by sponging and sequestering miR-23c

  2023cites this paper
• Prevalence of Microalbuminuria Among Diabetes Patients in Africa: A Systematic Review and Meta-Analysis

  2023cites this paper
• Human Umbilical Cord Mesenchymal Stem Cells Inhibit Pyroptosis of Renal Tubular Epithelial Cells through miR-342-3p/Caspase1 Signaling Pathway in Diabetic Nephropathy

  2023cites this paper
• Deletion of protein tyrosine phosphatase SHP-1 restores SUMOylation of podocin and reverses the progression of diabetic kidney disease.

  2023cites this paper
• Increased Renal Medullary NOX-4 in Female but Not Male Mice during the Early Phase of Type 1 Diabetes: Potential Role of ROS in Upregulation of TGF-β1 and Fibronectin in Collecting Duct Cells

  2023cites this paper
• The Effect of Chinese Medicinal Formulas on Biomarkers of Oxidative Stress in STZ-Induced Diabetic Kidney Disease Rats: A Meta-Analysis and Systematic Review

  2022cites this paper
• -54-Progress in the correlation of mitochondrial dysfuncti on and diabetic kidney disease

  2022cites this paper
• NAD+ Anabolism Disturbance Causes Glomerular Mesangial Cell Injury in Diabetic Nephropathy

  2022cites this paper
• Tibial cortex transverse transport accelerates wound healing via enhanced angiogenesis and immunomodulation

  2022cites this paper
• Identification of Active Component of Hachimi-jio-gan Ameliorating Diabetic Nephropathy

  2022cites this paper
• Triplanar osteotomy combined with proximal tibial transverse transport to accelerate healing of recalcitrant diabetic foot ulcers

  2022cites this paper
• Emerging Role of LncRNA Regulation for NLRP3 Inflammasome in Diabetes Complications

  2022cites this paper
• GCMS fingerprints and phenolic extracts of Allium sativum inhibit key enzymes associated with type 2 diabetes

  2022cites this paper
• ASH2L Aggravates Fibrosis and Inflammation through HIPK2 in High Glucose-Induced Glomerular Mesangial Cells

  2022cites this paper
• Association between Triglycerides to High-Density Lipoprotein Cholesterol Ratio and Death Risk in Diabetic Patients with New-Onset Acute Coronary Syndrome: A Retrospective Cohort Study in the Han Chinese Population

  2022cites this paper
• The effect of diabetes and the diabetogenic TBC1D4 p.Arg684ter variant on kidney function in Inuit in Greenland

  2022cites this paper
• Impact of SGLT2 inhibitors on the kidney in people with type 2 diabetes and severely increased albuminuria

  2022cites this paper
• An examination of the protective effects and molecular mechanisms of curcumin, a polyphenol curcuminoid in diabetic nephropathy.

  2022cites this paper
• Effect of BBT-877, a novel inhibitor of ATX, on a mouse model of type 1 diabetic nephropathy

  2022cites this paper
• Association between triglycerides to high-density lipoprotein cholesterol ratio and death risk in diabetic patients with new-onset acute coronary syndrome：a retrospective cohort study in Han Chinese population

  2022cites this paper
• Telomere Lengths and Serum Proteasome Concentrations in Patients with Type 1 Diabetes and Different Severities of Diabetic Retinopathy in Latvia and Lithuania

  2022cites this paper
• Trimetazidine an emerging paradigm in renal therapeutics: Preclinical and clinical insights.

  2021cites this paper
• Interobserver reproducibility of contrast-enhanced ultrasound in diabetic nephropathy.

  2021cites this paper
• Podocyte Bioenergetics in the Development of Diabetic Nephropathy: The Role of Mitochondria

  2021cites this paper
• Atorvastatin calcium tablets on inflammatory factors, hemorheology and renal function damage indexes in patients with diabetic nephropathy

  2021cites this paper
• Predictive Value of the Triglyceride to High-Density Lipoprotein Cholesterol Ratio for All-Cause Mortality and Cardiovascular Death in Diabetic Patients With Coronary Artery Disease Treated With Statins

  2021cites this paper
• Protective Role of Fisetin in STZ Induced Diabetic Nephropathy in Rats

  2021cites this paper
• Potential therapeutic value of melatonin in diabetic nephropathy: improvement beyond anti-oxidative stress

  2021cites this paper
• Elevated Urinary VEGF-A, Transferrin, and Angiotensinogen Levels in Normoalbuminuric Children and Adolescents with Type 1 Diabetes: Can They Be Early Markers of Diabetic Kidney Disease?

  2021cites this paper
• Epidermal Growth Factor Receptor: A Potential Therapeutic Target for Diabetic Kidney Disease

  2021cites this paper
• The association between monocyte HDL ratio and albuminuria in diabetic nephropathy

  2021cites this paper
• NQO1 Deficiency Aggravates Renal Injury by Dysregulating Vps34/ATG14L Complex during Autophagy Initiation in Diabetic Nephropathy

  2021cites this paper
• Matrix metalloproteinase-9 gene polymorphism (-1562 C/T) and its correlation with diabetic nephropathy

  2021cites this paper
• Inflammatory Cytokines in Diabetic Kidney Disease: Pathophysiologic and Therapeutic Implications

  2021cites this paper
• Potential mechanisms underlying the renoprotective effect of empagliflozin, a novel selective sodium glucose co-transporter (SGLT) 2 inhibitor, against diabetic nephropathy in streptozotocin induced diabetic rats

  2021cites this paper
• Diabetische Nephropathie

  2021cites this paper
• MORG1—A Negative Modulator of Renal Lipid Metabolism in Murine Diabetes

  2021cites this paper
• The Role of Non-coding RNAs in Diabetic Nephropathy-Related Oxidative Stress

  2021cites this paper
• Sirtuins in diabetes mellitus and diabetic kidney disease

  2021cites this paper
• Diabetic foot ulcers: Retrospective comparative analysis from Sicily between two eras

  2021cites this paper
• Renoprotective Roles of Curcumin.

  2021cites this paper
• Hyperglycemia alters mitochondrial respiration efficiency and mitophagy in human podocytes.

  2021cites this paper
• Pathophysiology of Diabetic Nephropathy

  2020cites this paper
• WJ-39, an Aldose Reductase Inhibitor, Ameliorates Renal Lesions in Diabetic Nephropathy by Activating Nrf2 Signaling

  2020cites this paper
• Ergosterol ameliorates renal inflammatory responses in mice model of diabetic nephropathy.

  2020cites this paper
• COMPARATIVE EVALUATION OF RENOPROTECTION BY VALSARTAN VS TRANDOLAPRIL IN STREPTOZOTOCIN INDUCED DIABETIC NEPHROPATHY

  2020cites this paper
• Diabetic Kidney Disease: It Don’t Get No Respect

  2020cites this paper
• A review of relationship between platelet indices and microvascular complications in type 2 diabetic patients

  2020cites this paper
• Protective effects of luteolin on nephrotoxicity induced by long-term hyperglycaemia in rats

  2020cites this paper
• Diabetic Nephropathy – Clinical

  2020cites this paper
• Acute Kidney Injury in Patients Undergoing Cardiopulmonary Bypass for Lung Transplantation.

  2020cites this paper
• Inflammatory Targets in Diabetic Nephropathy

  2020influential citation
• Thymol alleviates AGEs-induced podocyte injury by a pleiotropic effect via NF-κB-mediated by RhoA/ROCK signalling pathway

  2020cites this paper
• Geschlechtsunterschiede bei der diabetischen Nephropathie

  2020cites this paper
• ADVANCED GLYCATED END PRODUCTS (AGES) IN DIABETES AND ITS COMPLICATIONS: AN INSIGHT

  2020cites this paper
• Porcine models for studying complications and organ crosstalk in diabetes mellitus

  2020influential citation
• Magnoflorine Ameliorates Inflammation and Fibrosis in Rats With Diabetic Nephropathy by Mediating the Stability of Lysine-Specific Demethylase 3A

  2020cites this paper
• Keap1/Nrf2/ARE signaling unfolds therapeutic targets for redox imbalanced-mediated diseases and diabetic nephropathy.

  2020cites this paper
• The atherogenic index of plasma plays an important role in predicting the prognosis of type 2 diabetic subjects undergoing percutaneous coronary intervention: results from an observational cohort study in China

  2020cites this paper
• Wogonin Ameliorates Renal Inflammation and Fibrosis by Inhibiting NF-κB and TGF-β1/Smad3 Signaling Pathways in Diabetic Nephropathy

  2020cites this paper
• Elabela levels in patients with type 2 diabetes: can it be a marker for diabetic nephropathy?

  2020cites this paper
• Deneysel Diyabetik Nefropatide Patomorfoloji ve Apoptozis

  2020cites this paper
• Sex Differences in Diabetes- and TGF-β1-Induced Renal Damage

  2020influential citation
• Effect of Olive Leaves Extract on Alloxan Induced Diabetes in Male Albino Mice

  2020cites this paper
• The relationship between urinary and plasma levels of tumor necrosis factor alpha and various stages of chronic kidney disease in patients with type II diabetes mellitus

  2020cites this paper
• Oxidative Stress Markers in Chronic Kidney Disease with Emphasis on Diabetic Nephropathy

  2020cites this paper
• A Review on Cellular and Molecular Mechanisms Linked to the Development of Diabetes Complications.

  2020cites this paper
• Treatment of Patient with Diabetic Nephropathy using Chinese Prescription Kangen-karyu

  2019cites this paper
• Effects of vitamin D supplementation on circulatory YKL-40 and MCP-1 biomarkers associated with vascular diabetic complications: A randomized, placebo-controlled, double-blind clinical trial.

  2019cites this paper
• The relationship between monocyte to high-density lipoprotein cholesterol ratio and diabetic nephropathy

  2019cites this paper
• Role of Vitamin D and Its Analogues in Diabetic Nephropathy: A Meta‐analysis

  2019cites this paper
• Nelumbo nucifera leaves extract attenuate the pathological progression of diabetic nephropathy in high-fat diet-fed and streptozotocin-induced diabetic rats

  2019cites this paper
• Infected Neuropathic Foot: Investigation

  2019cites this paper
• Ameliorative effect of polydatin on hyperglycemia and renal injury in streptozotocin-induced diabetic rats.

  2019cites this paper
• High glucose and TGF-β1 reduce expression of endoplasmic reticulum-resident selenoprotein S and selenoprotein N in human mesangial cells

  2019cites this paper
• Diabetic Nephropathy

  2019influential citation